Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood.
about
Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: a new syndrome of defective fibroblast growth factor 19 releaseMethods for diagnosis of bile acid malabsorption in clinical practiceControversies in the Mechanism of Total Parenteral Nutrition Induced PathologyBile Acid diarrhea: prevalence, pathogenesis, and therapyInhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in miceBile acid malabsorption in chronic diarrhea: pathophysiology and treatment.Marked variability in hepatic expression of cytochromes CYP7A1 and CYP27A1 as compared to cerebral CYP46A1. Lessons from a dietary study with omega 3 fatty acids in hamsters.Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorptionSelective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid miceGenetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.Thyroid hormone induction of human cholesterol 7 alpha-hydroxylase (Cyp7a1) in vitro.Thyroid hormones and thyroid hormone receptors: effects of thyromimetics on reverse cholesterol transport.Validating biomarkers of treatable mechanisms in irritable bowel syndromeEffects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.Specific inhibition of bile acid transport alters plasma lipids and GLP-1Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndromeProfiling sterols in cerebrotendinous xanthomatosis: utility of Girard derivatization and high resolution exact mass LC-ESI-MS(n) analysisIncreased Bile Acid Synthesis and Deconjugation After Biliopancreatic DiversionThyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans.Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis.The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humansPharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice.Dietary fish oil increases fat absorption and fecal bile acid content without altering bile acid synthesis in 20-d-old weanling rats following massive ileocecal resection.Measurement of serum 7α-hydroxy-4-cholesten-3-one as a marker of bile acid malabsorption in dogs with chronic diarrhoea: a pilot study.Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometryDetermination of key intermediates in cholesterol and bile acid biosynthesis by stable isotope dilution mass spectrometry.A blood test for cerebrotendinous xanthomatosis with potential for disease detection in newborns.New insights into bile acid malabsorption.Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7alpha-hydroxylase (Cyp7a1) in leptin-deficient (ob/ob) mice.Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis.Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea.Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.The ascending pathophysiology of cholestatic liver disease.Hepatic deletion of X-box binding protein 1 impairs bile acid metabolism in mice.Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS.Obesity is associated with changes in oxysterol metabolism and levels in mice liver, hypothalamus, adipose tissue and plasma.The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism.Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea.Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism.
P2860
Q24603434-75B81420-7622-4F94-83D3-B9638FE6478EQ24618216-7F4F81BC-0A27-4245-95D3-3F3C699DBB0DQ26865276-271B3D66-E82C-44F0-B987-28AEE44BD544Q28086845-C919B198-1E60-492E-A06C-15D9DA412CA5Q28729212-36364806-BA34-43AE-8049-62CFC3DDA18EQ33459719-38EBB549-5922-43B2-8FD6-57D5DAC9900CQ33835559-F1F364A6-019E-40D0-9DA2-53C26F20BA52Q33868781-EAB54A3A-14E4-4E5F-80BB-6B442AA92F61Q33900633-F34DFAE2-013A-404F-8325-7799BE2828F1Q34131127-5685CA85-50B2-4ACB-865F-2D2860C8A7A5Q34270093-4E41D558-61AF-4CA9-A123-FC71BBA7B931Q34428756-01B9B3AF-F2A6-48EA-9AB8-0BEFFD0C6048Q34577283-FC754B43-B929-4F0E-88EF-7029689F6673Q35590298-9FB2CE16-53A1-43E3-8B7C-9E865BB13E4AQ35703890-FFC408BB-2E85-4B36-8E4B-310E2D7BEF62Q35825711-61244CF5-E27E-48A0-9928-1221B977798BQ35888076-44A53F26-3A21-40FD-AC0B-41D8844D6420Q36104655-7107E4A2-AB7F-4960-9E8D-97A6338D0184Q36196859-2E7A6199-9B95-421A-8F3B-779504DAB41DQ36389501-8958D964-1753-4330-8B8A-DD25F8A3E127Q36392977-51D86C5D-8DA7-4E97-B2B8-C833E9025F41Q36464051-5CA01B14-AAD9-4BC4-8BDD-460E2AF33E3DQ36602438-086F09BF-0421-4FE6-986D-F8C20A496C30Q36819297-81A48471-5C7F-4727-93A1-130EFB2B692DQ37250395-403F1F57-AD0C-4256-A46F-7255F67827F9Q37553945-9D8C6A76-1D5E-4B9B-8EEF-457029A34404Q37590260-51F687D5-35B0-4175-83EF-2E81BFC087F9Q37909078-F7E6CD85-B333-4EC6-837A-4279FA92911DQ38351474-F02B92AB-9F87-488F-87BB-47763FF86651Q38582664-92C9B95B-7158-430B-87DE-3BF816DFE13FQ38687017-C71A0C89-2F4F-4F3F-90FC-4E0E99ECC386Q38699388-D1E7453C-4674-41F3-B4CA-D29970BC5FE8Q39040911-E0207E37-10F7-4E02-9694-2C7DD5FA89A3Q39048675-AEC4EDC3-15F0-4C37-B687-4018917D4C48Q39179801-3BDB6640-FC01-4850-A20B-5E4B4FF501E4Q39208620-FF8CD57F-7FB7-47B2-B516-B836357687F3Q40077482-ECEBCEB8-30CC-42A8-AD65-8BF825B9E938Q42096573-49BA3909-4003-4323-81B0-A5AFF2A138B6Q42263341-7AE3C659-092D-4A39-9655-E164BCA64F66Q42622908-020723C7-A382-4AD0-9DC5-CDD05ADD3235
P2860
Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Monitoring hepatic cholesterol ...... ten-3-one in peripheral blood.
@en
Monitoring hepatic cholesterol ...... ten-3-one in peripheral blood.
@nl
type
label
Monitoring hepatic cholesterol ...... ten-3-one in peripheral blood.
@en
Monitoring hepatic cholesterol ...... ten-3-one in peripheral blood.
@nl
prefLabel
Monitoring hepatic cholesterol ...... ten-3-one in peripheral blood.
@en
Monitoring hepatic cholesterol ...... ten-3-one in peripheral blood.
@nl
P2093
P2860
P1476
Monitoring hepatic cholesterol ...... ten-3-one in peripheral blood.
@en
P2093
Bo Angelin
Cecilia Gälman
Ingela Arvidsson
Mats Rudling
P2860
P304
P356
10.1194/JLR.D200043-JLR200
P577
2003-01-16T00:00:00Z